mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-10 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-10 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
6e-10 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
8e-10 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-10 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |